Le SIDA en Afrique subsaharienne (serveur d'exploration) - Merge (Accueil)

Index « Idat.i » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : Idat.i

Pour accéder à une entrée :

Les termes de plus forte occurence

50001-9909:2008:Barringer T:a:select:list
40001-9909:2009:Barringer T:a:select:list
40001-9909:2007:Barringer T:a:select:list
40001-9909:2006:Barringer T:a:select:list
40001-9909:2005:Barringer T:a:select:list
40001-9909:2004:Barringer T:a:select:list
31403-4948:2003:Ndubani P:understanding:young:men
30954-0121:1995:Campbell T:women:and:aids
30277-9536:2001:Malungo J:sexual:cleansing:kusalazya
30266-4348:1996:Low N:aids:survival:and
30039-3665:2010:Benefo K:determinants:of:condom
30001-9909:2010:Barringer T:a:select:list
22141-9248:2014:Ikeako L:seroprevalence:of:human
22006-0165:2016:Egwuatu C:effect:of:trimethoprim
21606-0997:2013:Peltzer K:socioeconomic:factors:in
21527-6546:2005:Phaladze N:quality:of:life
21525-4135:2009:Kuhn L:mortality:and:virologic
21525-4135:2008:Khumalo Sakutukwa G:project:accept:hptn
21525-4135:2008:Fox M:reduced:mortality:associated
21403-4948:2009:Schaalma H:correlates:of:intention
21368-4973:2013:Chemaitelly H:external:infections:contribute
21368-4973:2012:Chemaitelly H:distinct:hiv:discordancy
21368-4973:2012:B Rnighausen T:health:systems:and
21368-4973:2011:Sikasote J:voluntary:counselling:and
21368-4973:2011:Orroth K:attempting:to:explain
21368-4973:2011:Lewis D:hiv:sexually:transmitted
21368-4973:2011:Heffron R:high:prevalent:and
21368-4973:2008:De Walque D:do:unsafe:tetanus
21368-4973:2006:Garcia Calleja J:national:population:based
21368-4973:2002:O Farrell N:genital:ulcers:stigma
21368-4973:1999:Leroy V:cervical:dysplasia:and
21368-4973:1999:Halperin D:dry:sex:practices
21363-4607:2007:Simpson A:learning:sex:and
21363-4607:1999:Ankomah A:sex:love:money
21360-2276:2012:Mugglin C:loss:to:programme
21360-2276:2011:Magadi M:cross:national:analysis
21359-1053:2003:Joffe H:social:representation:of
21354-523X:2002:Bekker L:the:epidemiology:and
21353-4505:1993:Britton M:el:papel:de
21118-4841:2013:Nketiah Amponsah E:a:review:of
21118-4841:2013:Guiella G:why:are:virgin
21118-4841:2013:Amo Adjei J:drivers:of:young
21115-2613::Obiako O:antiretroviral:drug:resistance
21081-0730:2000:Wolf R:peer:promotion:programs
21073-1105:2001:Marks S:jonathan:mann:s
21072-4745:2010:Booth K:a:magic:bullet
21058-4838:2012:Gompels U:human:cytomegalovirus:infant
21058-4838:2010:Mulenga V:strategies:for:nevirapine
21058-4838:2010:Makadzange A:early:versus:delayed
21058-4838:2010:Howard A:integration:of:tuberculosis
21058-4838:2008:Sutcliffe C:survival:from:months
21058-4838:2006:Wester C:serological:evidence:of
21058-4838:2006:Sellier P:comparative:evaluation:of
21058-4838:2005:Wester C:establishment:of:a
21058-4838:2003:Holmes C:review:of:human
21058-4838:2002:Chorba T:assessing:eosinophil:count
21055-9965:2008:Wojcicki J:mortality:among:hiv
21054-139X:2001:Brieger W:west:african:youth
21054-139X:1999:Adih W:determinants:of:condom
21052-9284:2006:Bond V:the:importance:of
21017-6772:1992:Vaidyanathan K:population:trends:issues
21017-6772:1992:Eshete A:population:and:women
20959-8138:2005:Robinson A:rising:rates:of
20959-8138:2005:Labonte R:a:global:health
20959-8138:2005:Khayesi M:road:safety:in
20959-8138:2003:Potts M:tackling:india:s
20959-8138:2002:Dixon S:the:impact:of
20959-8138:2002:Dabis F:improving:child:health
20959-8138:2001:Muller O:effect:of:zinc
20959-8138:2001:Mckee M:understanding:the:toll
20959-8138:1999:Raleigh V:world:population:and
20959-8138:1998:Wilkinson D:effect:of:preventive
20959-8138:1997:Veeken H:tajikistan:no:pay
20959-8138:1997:Veeken H:sudan:eating:dust
20959-8138:1997:Taha T:effect:of:cleansing
20959-8138:1997:Reyes H:pitfalls:of:tuberculosis
20959-8138:1997:O Brien E:walk:in:peace
20959-8138:1997:Nunn A:mortality:associated:with
20959-8138:1997:M Kel P:contribution:of:deaths
20959-8138:1997:King M:to:the:point
20959-8138:1997:Jewell D:supporting:diversity:in
20959-8138:1997:Hornblum A:they:were:cheap
20959-8138:1997:Giannou C:antipersonnel:landmines:facts
20959-8138:1997:Fenton K:race:ethnicity:and
20959-8138:1997:De Laet C:bone:density:and
20959-8138:1997:Coupland R:abhorrent:weapons:and
20959-8138:1995:Wilson M:infectious:diseases:an
20959-8138:1995:Mulder D:decreasing:hiv:seroprevalence
20959-8138:1995:Darbyshire J:tuberculosis:old:reasons
20959-8138:1995:Bhatti N:increasing:incidence:of
20959-8138:1994:Johnson A:what:s:happening
20959-8138:1991:Wawer M:dynamics:of:spread
20956-4624:2007:Strand R:unexpected:low:prevalence
20954-0121:2014:Medley A:alcohol:use:and
20954-0121:2013:Singh K:gender:equality:and
20954-0121:2011:Chepngeno Langat G:gender:differentials:on
20954-0121:2010:Robertson L:sexual:risk:among
20954-0121:2009:Stephenson R:community:factors:shaping
20954-0121:2009:Hosegood V:the:demographic:impact
20954-0121:2009:Heymann J:hiv:aids:declining
20954-0121:2008:Stephenson R:the:influence:of
20954-0121:2007:Mendenhall E:property:grabbing:and
20954-0121:2007:Foster G:under:the:radar
20950-2688:2004:Wojcicki J:low:socioeconomic:status
20926-9959:1996:Dimian C:sexually:transmitted:diseases
20899-9546:1998:Ankomah A:condom:use:in
20899-9546:1994:Scott S:understanding:cultural:obstacles
20892-6794:2007:Donnelly E:making:the:case
20856-8960:2010:Ghezehay K:knowledge:attitudes:and
20767-0974:2008:Calvez M:acces:tardif:aux
20379-5721:2010:Semba R:addressing:tuberculosis:in
20376-8716:2011:Brodish P:evidence:of:high
20340-0352:2002:Nicholson D:the:information:starved
20309-2402:2004:Rassool G:current:issues:and
20309-2402:2004:Hussein Rassool G:current:issues:and
20305-7453:2010:Bratholm C:drug:resistance:is
20300-5771:2012:Crampin A:profile:the:karonga
20300-5771:2010:Murnane P:lactation:associated:postpartum
20300-5771:2008:Londish G:significant:reduction:in
20300-5771:2006:Jewkes R:factors:associated:with
20300-5771:2004:Gustafson P:tuberculosis:in:bissau
20277-9536:2014:Moore A:bucking:social:norms
20277-9536:2009:Ssewamala F:asset:ownership:and
20277-9536:2009:Maman S:a:comparison:of
20277-9536:2009:Genberg B:a:comparison:of
20277-9536:2001:Painter T:voluntary:counseling:and
20277-9536:2001:Bosompra K:determinants:of:condom
20277-9536:2000:Maman S:the:intersections:of
20277-9536:1997:Feldman D:hiv:prevention:among
20277-9536:1997:Caldwell J:male:and:female
20277-9536:1997:Bond V:the:difficulties:of
20269-994X:2012:Maro C:combating:hiv:aids
20269-9370:2013:Siedner M:gps:measured:distance
20269-9370:2013:Haddad L:contraceptive:discontinuation:and
20269-9370:2013:Abu Raddad L:have:the:explosive
20269-9370:2012:Vermund S:transitioning:hiv:care
20269-9370:2011:Nash D:program:level:and
20269-9370:2011:Kandala N:millennium:development:goal
20269-9370:2009:Golub J:isoniazid:preventive:therapy
20269-9370:2008:Ciaranello A:antiretroviral:drugs:for
20269-9370:2007:Moh R:incidence:and:determinants
20269-9370:2006:Wools Kaloustian K:viability:and:effectiveness
20269-9370:2002:Agha S:declines:in:casual
20269-9370:1997:Fylkesnes K:the:hiv:epidemic
20266-4348:1997:Mabey D:sexually:transmitted:diseases
20266-4348:1997:Klouman E:serological:markers:for
20266-4348:1997:Day S:sex:workers:and
20266-4348:1996:Adler M:sexually:transmitted:diseases
20266-4348:1995:O Farrell N:aids:in:africans
20266-4348:1994:Pellow D:stds:and:aids
20266-4348:1994:Donovan B:male:circumcision:and
20266-4348:1994:Daly C:risk:factors:for
20266-4348:1991:Gibb D:the:family:and
20266-4348:1989:O Farrell N:sexually:transmitted:pathogens
20196-206X:2011:Vaz L:patterns:of:disclosure
20163-4453:1998:Harries A:tuberculosis:in:hiv
20148-5717:2010:Voeten H:strong:association:between
20146-6615:2009:Lukhwareni A:increased:detection:of
20146-6615:2009:Bates M:predominant:human:herpesvirus
20146-6615:2007:Selabe S:mutations:associated:with
20146-6615:2005:Klaskala W:epidemiological:characteristics:of
20146-6615:2004:Fischetti L:molecular:epidemiology:of
20146-6615:2000:Candotti D:aids:in:an
20145-2134:2007:Slonim Nevo V:child:abuse:and
20144-333X:2002:Benefo K:mass:media:effects
20143-005X:2013:Hargreaves J:does:the:inverse
20143-005X:1998:Ransjo Arvidson A:maternal:and:infant
20142-6338:2009:Cooke M:endoscopy:findings:in
20142-6338:2006:Setse R:hiv:infection:as
20140-6736:2001:Harries A:deaths:from:tuberculosis
20140-6736:2001:Attaran A:defining:and:refining
20140-6736:2000:Wood E:extent:to:which
20140-6736:1999:Marseille E:cost:effectiveness:of
20140-6736:1996:Quinn T:global:burden:of
20140-6736:1995:Foster S:benefits:of:hiv
20140-6736:1994:Decosas J:fighting:aids:or
20098-7921:2011:Westoff C:the:association:of
20098-7921:2011:Gregson S:social:capital:and
20095-2583:2011:Ferreira P:the:impact:of
20093-7754:2001:Thomas J:acquired:immunodeficiency:syndrome
20090-0036:2005:Mccoy D:expanding:access:to
20042-9686:2014:Chi B:universal:combination:antiretroviral
20042-9686:2006:Taha T:the:impact:of
20042-9686:2001:Piot P:international:response:to
20042-9686:1999:Baggaley R:hiv:stress:in
20040-6376:1998:Heyderman R:pulmonary:tuberculosis:in
20040-6376:1995:Malin A:escalating:threat:from
20039-3665:2012:Luke N:migration:experience:and
20039-3665:2012:Koffi A:correlates:of:and
20039-3665:2012:Hayford S:now:or:never
20039-3665:2012:Clark S:dating:sex:and
20039-3665:2011:Mwaikambo L:what:works:in
20039-3665:2011:Mojola S:multiple:transitions:and
20039-3665:2008:Moultrie T:refining:the:criteria
20039-3665:2008:Mensch B:sexual:behavior:and
20039-3665:2008:Marteleto L:sexual:behavior:pregnancy
20039-3665:2008:Harrison A:young:people:s
20039-3665:2004:Clark S:early:marriage:and
20037-8046:2010:Hodge D:sub:saharan:african
20035-9203:2006:Toure S:incidence:of:neutropenia
20035-9203:2000:Zulu I:contrasting:incidence:of
20035-9203:1999:Kelly P:hiv:and:tuberculosis
20035-9203:1996:Oshitani H:prevalence:of:hepatitis
20035-9203:1995:Elliott A:the:impact:of
20035-9203:1994:Kelly P:cutaneous:reactions:to
20032-5473:2001:Mwaba P:clinical:presentation:natural
20029-6643:2008:Kimokoti R:nutrition:health:and
20028-0836:2006:Aledort J:reducing:the:burden
20025-682X:1993:Remy G:l:espace:epidemiologique
20022-4200:2012:Van Klinken A:men:in:the
20022-278X:2005:Mabizela M:higher:education:in
20022-1899:2012:Ezeamama A:hiv:infection:and
20022-1899:2009:Mayaud P:impact:of:acyclovir
20022-1899:2005:Litvintseva A:prevalence:of:clinical
20022-1899:2003:Brayfield B:postnatal:human:herpesvirus
20022-1899:1999:Kanki P:human:immunodeficiency:virus
20022-1465:2011:Manglos N:the:third:therapeutic
20021-9630:2008:Earls F:promoting:child:and
20021-9320:2013:Brodish P:an:association:between
20021-9320:2007:Baiden F:using:lay:counsellors
20021-9096:2010:Damar A:coping:versus:grieving
20021-9096:1999:Lugalla J:the:social:and
20016-5085:2000:Kelly P:mannose:binding:lectin
20012-155X:2011:Budlender D:south:africa:a
20010-7824:1998:Hardy E:women:s:preferences
20007-1323:1996:Bem C:importance:of:human
20007-1161:2003:Courtright P:changes:in:blindness
20007-0920:2007:Sahasrabuddhe V:prevalence:and:distribution
20003-9888:1999:Bannon M:bcg:and:tuberculosis
20002-9637:2005:Modjarrad K:prevalence:and:predictors
20002-9637:2005:Duda R:hiv:prevalence:and
20002-9602:2010:Mcdonnell T:cultural:objects:as
20002-9262:2010:Chi B:an:empirical:approach
20002-9262:2008:Minhas V:early:childhood:infection
20001-9909:2002:Townsend R:a:select:list
20001-706X:1996:Kelly P:the:prevalence:and
18756-3282:1988:Lecanda F:impaired:intramembranous:bone
18755-6863:2011:Pitcher R:chest:radiographic:presenting
18755-6863:2008:Zar H:chronic:lung:disease
18755-6863:2007:Zar H:child:lung:health
18755-6863:2004:Zar H:tuberculosis:in:the
18755-6863:2003:Zar H:global:burden:of
18755-6863:2003:Graham S:impact:of:hiv
18755-1039:2012:Field A:assisting:cytopathology:training
18755-1039:2011:Pantanowitz L:review:of:human
18755-1039:2005:Knight B:project:screen:south
12469-4452:2016:Herrick C:global:health:geographical
12469-2964:2017:Belaunzaran Zamudio P:immunologic:effects:of
12451-8654:2017:Ruzagira E:an:open:label
12405-4704:2017:O Connor J:durability:of:viral
12405-4704:2016:Yotebieng M:conditional:cash:transfers
12398-502X:2017:Sharp C:parv:prevalence:phylogeny
12369-2960:2017:Rao A:sampling:key:populations
12369-2960:2017:Fakoya I:factors:associated:with
12369-2960:2017:Chard A:perceptions:of:hiv
12356-7104:2016:Dickson K:what:influences:where
12356-6140:2016:Daw M:hepatitis:c:virus
12356-6140:2014:Kretzer I:hepatitis:c:worldwide
12356-6140:2013:Tey N:correlates:of:and
12356-6140:2012:Da Silva A:study:of:the
12356-6140:2011:Gabriel A:evaluation:of:task
12352-5789:2017:Ghebre R:cervical:cancer:control
12347-5625:2017:Walker D:cancer:and:palliative
12329-6933:2014:Piddock K:a:cross:sectional
12328-8957:2017:Walaza S:the:burden:and
12328-8957:2017:Shenoi S:integrated:tuberculosis:human
12328-8957:2017:Ryan K:high:rates:of
12328-8957:2017:Flynn A:evolving:failures:in
12325-9574::Winston S:evaluation:of:longitudinal
12325-9574::Tieno H:characteristics:and:follow
12325-9574::Tetteh R:outcomes:of:a
12325-9574::Shacham E:perceptions:of:male
12325-9574::Peterson K:use:of:self
12325-9574::Okyere G:determinants:of:survival
12325-9574::Michalik D:differences:in:viral
12325-9574::Mdodo R:investigation:of:hiv
12325-9574::Lifson A:failure:to:test
12325-9574::Kwan C:utility:of:cryptococcal
12325-9574::Katusiime C:characteristics:of:sexually
12325-9574::Deribe K:predictors:of:mortality
12325-9574::Abgrall S:visiting:one:s
12325-9574:2016:Wagner G:depression:at:treatment
12325-9574:2016:Ranjbar V:the:battle:over
12325-9574:2014:Semu H:prevalence:and:risk
12325-9574:2014:Jones D:antiretroviral:therapy:in
12325-9574:2013:Sullivan P:safety:and:acceptability
12325-9574:2013:Ngo V:a:qualitative:analysis
12325-9574:2013:Mwiru R:nutritional:status:and
12325-9574:2013:Cohen G:role:of:education
12325-9574:2012:Winston S:evaluation:of:longitudinal
12325-9574:2012:Poles G:factors:associated:with
12325-8292:2016:Shaw S:descriptive:epidemiology:of
12322-5939:2013:Kaboru B:tb:hiv:co
12322-1488:2016:Sooki Z:the:role:of
12314-8861:2017:Kimuda S:humoral:responses:to
12314-6745:2017:Mukona D:barriers:of:adherence
12314-6745:2016:Omech B:validity:of:the
12314-6133:2017:Nii Trebi N:emerging:and:neglected
12314-6133:2017:Mkhize B:the:interaction:between
12314-6133:2017:Draper C:developing:intervention:strategies
12314-6133:2016:Matthews L:i:always:worry
12314-6133:2016:Lumsden R:the:causes:of
12314-6133:2016:Cheng W:late:presentation:of
12314-6133:2015:Van Dunem J:effectiveness:of:the
12314-6133:2015:Starita N:identification:of:human
12314-6133:2015:Hancock N:temporal:trends:and
12314-6133:2015:Gizachew Balew J:structural:determinants:in
12314-6133:2014:Olatunbosun O:prevalence:of:anaemia
12314-6133:2014:Liu Y:alcohol:use:among
12314-6133:2014:Cheepsattayakorn A:parasitic:pneumonia:and
12314-6133:2014:Alvarez Uria G:directly:observed:intermittent
12314-6133:2013:Petrone L:cystic:echinococcosis:in
12314-6133:2013:Mohamed B:factors:associated:with
12314-6133:2013:Alvarez Uria G:predictors:of:delayed
12314-4327:2017:Gebremariam E:prevalence:and:associated
12314-4327:2014:Atilola O:where:lies:the
12312-0053:2017:Moodley Y:relationship:between:hiv
12296-2565:2017:Lentoor A:psychosocial:challenges:associated
12296-2565:2017:Bhatia D:the:role:of
12279-9028:2013:Fletcher S:prevalence:of:gastrointestinal
12279-9028:2012:Chen N:hiv:risk:behaviours
12261-3684:2014:Sagna Y:profil:biologique:des
12251-6581:2017:Shankalala P:risk:factors:for
12251-6085:2015:Yazdi Feyzabadi V:the:association:between
12251-6085:2015:Tola H:tuberculosis:treatment:non
12251-6085:2015:Peltzer K:drinking:and:driving
12251-6085:2013:Fahimfar N:counseling:and:harm
12251-6085:2012:Holakouie Naieni K:malaria:status:in
12251-6085:2010:Adedimeji A:impact:of:care
12250-1541:2013:Giri P:prevalence:of:pulmonary
12250-1541:2012:Sonkar S:clinical:profile:of
12250-1541:2010:Bourne P:perception:attitude:and
12249-782X:2016:Hasabi I:a:study:of
12249-4863:2016:Bodunde O:perception:of:red
12249-4863:2012:Banerjee A:access:to:health
12234-7550:2017:Frimpong P:oral:manifestations:and
12230-8210:2011:Kalra S:south:asian:consensus
12229-5178:2014:Tao X:high:prevalence:of
12229-5151:2014:Pal R:the:academic:college
12228-5482:2010:Tarahomi M:preventing:mother:to
12225-2002:2017:Aliyu G:diagnostic:system:strengthening
12223-9170:2017:Hanass Hancock J:these:are:not
12223-9170:2014:Rhoda A:health:related:quality
12223-9170:2014:Abimanyi Ochom J:uganda:s:disability
12223-9170:2013:Hanass Hancock J:disability:and:hiv
12223-3652:2016:Ofori Asenso R:cardiovascular:diseases:in
12222-3959:2017:Amsalu A:ocular:manifestation:and
12221-1691:2013:Paydary K:the:emergence:of
12221-1691:2012:Gonzalez L:infections:and:inequalities
12220-8372:2013:Palanivel C:uptake:of:hiv
12215-0366:2017:Kariuki S:burden:risk:factors
12213-2600:2014:Gordon S:respiratory:risks:from
12213-2600:2014:Dheda K:global:control:of
12213-1779:2015:Bloomfield G:human:immunodeficiency:virus
12213-1027:2012:Manjoo R:the:continuum:of
12212-0661:2013:Barmania F:c:c:chemokine
12211-8160:2015:Miranda J:building:a:platform
12211-8160:2014:Lagat D:factors:associated:with
12211-8160:2014:Checkley W:management:of:noncommunicable
12211-3355:2017:Chen D:comparing:geographic:area
12210-9730:2011:Onzivu W:re:invigorating:the
12210-9730:2008:Mubangizi J:protecting:human:rights
12199-1154:2016:Engelhard E:patients:willingness:to
12198-1833:2015:Keetile M:patterns:and:determinants
12196-8799:2017:Pardo G:cultural:adaptation:of
12194-6353:2012:Coscia M:the:structure:and
12194-6299:2012:Wilmoth J:a:new:method
12193-8229:2017:Engelhard E:a:survey:of
12193-8229:2017:Bailey J:a:review:of
12191-1231:2012:Muula A:religion:is:not
12191-1231:2009:Basinga P:assessment:of:the
12191-1231:2007:Durvasula R:alcohol:use:and
12190-393X:2011:Akil A:development:and:characterization
12169-575X:2013:Sarna A:effectiveness:of:a
12169-575X:2013:Mills E:can:we:stop
12168-6203:2013:Lipshultz S:cardiac:status:of
12167-6461:2017:Patterson M:detecting:spatial:patterns
12167-6461:2015:Bram J:utilization:and:monetization
12164-5515:2016:Kane M:editorial:on:what
12164-5515:2015:Tchidjou H:low:vaccine:coverage
12164-5515:2015:Sequera V:vaccinations:in:prisons
12164-5515:2014:Esteban Vasallo M:sociodemographic:characteristics:and
12164-5515:2014:Dhalla S:effect:of:race
12161-8674:2017:Hampanda K:hiv:positive:women
12161-8674:2016:Worku E:factors:that:influence
12161-8674:2016:Njim T:late:pregnancy:outcomes
12161-8674:2015:Singh G:increasing:area:deprivation
12161-8674:2015:Azuine R:exclusive:breastfeeding:and
12161-8674:2015:Azuine R:ebola:virus:disease
12161-8674:2014:Modlin C:nutritional:deficiencies:and
12161-8674:2013:Laar A:individual:and:community
12161-8674:2013:Gyimah A:contraceptive:characteristics:of
12161-8674:2012:Singh G:global:inequalities:in
12161-8674:2012:Azuine R:addressing:global:health
12161-8313:2013:Jones A:what:are:we
12161-8313:2012:Perez Escamilla R:scaling:up:of
12161-8313:2011:Young S:current:knowledge:and
12160-8814:2012:Wagner G:depression:and:its
12155-6113:2013:Nachega J:adherence:to:antiretroviral
12155-6113:2013:Musubire A:diagnosis:and:management
12155-6113:2013:Manda S:risk:of:death
12153-957X:2012:Singer M:syndemics:and:human
12153-957X:2012:Singer M:interlocked:infections:the
12153-957X:2012:Romero Aza N:syndemic:theory:as
12153-957X:2012:Himmelgreen D:tourism:economic:insecurity
12153-957X:2011:Verheijen J:complexities:of:the
12153-957X:2011:Singer M:toward:a:critical
12153-957X:2011:Sellen D:food:insecurity:and
12153-957X:2011:Samuels F:twelve:years:on
12153-957X:2011:Mazzeo J:the:double:threat
12153-957X:2011:Mazzeo J:introduction:anthropologists:confront
12153-957X:2011:Maes K:cycles:of:poverty
12153-957X:2011:Jones C:if:i:take
12153-957X:2011:Hitchcock R:food:health:development
12153-957X:2011:Copeland T:poverty:nutrition:and
12153-957X:2011:Brenton B:contested:strategies:for
12150-5594:2010:Singer M:pathogen:pathogen:interaction
12141-9248:2016:Onyemaechi N:the:public:health
12141-9248:2016:Iroezindu M:factors:associated:with
12141-9248:2016:Iroezindu M:disparities:in:the
12141-9248:2014:Ezeala Adikaibe B:pattern:of:medical
12141-9248:2013:Kangbai J:lurking:dangers:behind
12141-9248:2013:Gupta S:slowly:rising:hilly
12141-9248:2013:Ezegwui H:investigating:maternal:mortality
12141-9248:2013:Anish T:revisiting:public:health
12141-9248:2012:Ubesie A:prevalence:of:human
12141-2359:2013:Ghebremichael M:the:effect:of
12090-939X:2013:Obirikorang C:predictors:of:adherence
12090-939X:2013:Antinori S:new:insights:into
12090-8113:2010:Awah Ndukum J:prevalence:of:bovine
12090-8091:2011:Palan M:breast:cancer:in
12090-8075:2016:Awoleye O:improving:access:to
12090-8075:2011:Kane E:prospects:and:pitfalls
12090-8032:2014:Mboowa G:genetics:of:sub
12090-8016:2015:Zaaqoq A:cardiovascular:complications:of
12090-7893:2017:Tetteh A:discordant:hiv:test
12090-7893:2017:Bamgboye E:transactional:sex:between
12090-7893:2016:Nakanwagi S:facilitators:and:barriers
12090-7893:2016:Mpondo B:new:biomedical:technologies
12090-7893:2014:Rastogi S:prevalence:and:predictors
12090-7893:2014:Beck Sague C:women:and:children
12090-7478:2013:Santoro M:hiv:genetic:variability
12090-5807:2013:Van Howe R:sexually:transmitted:infections
12090-5661:2013:Marais L:osteosarcoma:in:adult
12090-5505:2012:Owolabi L:stroke:in:young
12090-5483:2012:Guruge S:towards:a:global
12090-2727:2012:Ezechi O:hiv:aids:tuberculosis
12090-2727:2011:Nuwagaba Biribonwoha H:the:impact:of
12090-2204:2010:Mba C:population:ageing:in
12090-214X:2012:Alasia D:a:single:center
12090-214X:2012:Abiodun M:cystatin:c:based
12090-2042:2013:Tsehaye W:assessment:of:preference
12090-1836:2015:Gomes N:differences:between:risk
12090-1836:2013:Narasimhan P:risk:factors:for
12090-150X:2014:Yang W:barriers:and:delays
12090-150X:2014:Kebede W:acceptance:of:provider
12090-150X:2014:Carlsson M:nurses:roles:and
12090-150X:2013:Melaku S:pastoralist:community:s
12090-150X:2013:Amo Adjei J:perspectives:of:stakeholders
12090-150X:2012:Boniface R:correlates:of:delayed
12090-1461:2012:Patel P:an:opportunity:for
12090-1321:2016:Bitew H:suicidal:ideation:attempt
12090-1321:2015:Schlebusch L:elevated:risk:of
12090-1267:2014:Melku M:prevalence:and:predictors
12090-1240:2017:Sarfo B:hiv:case:management
12090-1240:2017:Hornschuh S:antiretroviral:treatment:adherence
12090-1240:2017:Gachara G:evaluating:adherence:to
12090-1240:2017:Belato D:male:partners:involvement
12090-1240:2016:Rukundo G:burden:of:suicidal
12090-1240:2016:Maskew M:insights:into:adherence
12090-1240:2016:Madiba S:perceptions:and:experiences
12090-1240:2016:Dionne Odom J:retention:in:care
12090-1240:2016:Dionne Odom J:factors:associated:with
12090-1240:2015:Berhan Y:a:meta:analysis
12090-1240:2014:Anyabolu H:serum:micronutrient:status
12090-1240:2013:Wachira J:psychometric:assessment:of
12090-1240:2013:Steinfeld R:overcoming:barriers:to
12090-1240:2013:Nannungi A:the:impact:of
12090-1240:2013:Larson B:same:day:cd
12090-1240:2013:Langs Barlow A:performance:of:clinical
12090-1240:2013:Cohen C:intersection:of:hiv
12090-1240:2012:Wagner G:a:qualitative:exploration
12090-1240:2012:Trehan I:challenges:in:the
12090-1240:2012:Reda A:determinants:of:adherence
12090-1240:2012:Newman J:older:adults:accessing
12090-1240:2012:Krishnan S:tanzanian:couples:perspectives
12090-1240:2012:Henderson W:symptom:status:predicts
12090-1240:2012:Boender T:barriers:to:initiation
12090-1240:2012:Adedimeji A:differences:in:the
12090-1240:2011:Tang A:predictors:of:weight
12090-1240:2011:Makumbi F:associations:between:hiv
12090-0422:2013:Kassi K:severe:skin:forms
12090-0384:2016:Njelekela M:prevalence:of:hypertension
12090-0384:2013:Mohan V:the:rising:burden
12090-0384:2011:Hamer M:depressive:symptoms:and
12090-0023:2016:Ngonjo T:current:status:of
12081-2221:2009:Zagnoli P:do:major:sports
12077-0383:2017:Badal Faesen S:impact:of:larger
12075-051X:2016:Katende G:shining:a:light
12075-051X:2007:Wangai A:from:hiv:abandonment

Manipulations en shell (Unix/Dilib)

HfdCat /applis/lorexplor/Wicri/Sante/explor/SidaSubSahara.storage/SidaSubSaharaV1.20171112/Data/Main/Merge/Idat.i.hfd| SxmlCut idx/l | grep ...  

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024